Annual Cash & Cash Equivalents
$399.27 M
+$122.79 M+44.41%
31 December 2023
Summary:
Ionis Pharmaceuticals annual cash & cash equivalents is currently $399.27 million, with the most recent change of +$122.79 million (+44.41%) on 31 December 2023. During the last 3 years, it has risen by +$1.60 million (+0.40%). IONS annual cash & cash equivalents is now -54.06% below its all-time high of $869.19 million, reached on 31 December 2021.IONS Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$334.61 M
+$40.61 M+13.81%
30 September 2024
Summary:
Ionis Pharmaceuticals quarterly cash and cash equivalents is currently $334.61 million, with the most recent change of +$40.61 million (+13.81%) on 30 September 2024. Over the past year, it has dropped by -$17.45 million (-4.96%). IONS quarterly cash and cash equivalents is now -61.50% below its all-time high of $869.19 million, reached on 31 December 2021.IONS Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IONS Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +44.4% | -5.0% |
| 3 y3 years | +0.4% | -47.1% |
| 5 y5 years | +43.2% | +35.0% |
IONS Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -54.1% | +44.4% | -61.5% | +21.0% |
| 5 y | 5 years | -54.1% | +44.4% | -61.5% | +35.0% |
| alltime | all time | -54.1% | >+9999.0% | -61.5% | >+9999.0% |
Ionis Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $334.61 M(+13.8%) |
| June 2024 | - | $293.99 M(-15.7%) |
| Mar 2024 | - | $348.89 M(-12.6%) |
| Dec 2023 | $399.27 M(+44.4%) | $399.27 M(+13.4%) |
| Sept 2023 | - | $352.06 M(-17.1%) |
| June 2023 | - | $424.79 M(+37.5%) |
| Mar 2023 | - | $309.03 M(+11.8%) |
| Dec 2022 | $276.47 M(-68.2%) | $276.47 M(-12.2%) |
| Sept 2022 | - | $314.99 M(-39.6%) |
| June 2022 | - | $521.92 M(-3.8%) |
| Mar 2022 | - | $542.51 M(-37.6%) |
| Dec 2021 | $869.19 M(+118.6%) | $869.19 M(+37.3%) |
| Sept 2021 | - | $632.95 M(+12.0%) |
| June 2021 | - | $565.12 M(+36.5%) |
| Mar 2021 | - | $414.15 M(+4.1%) |
| Dec 2020 | $397.66 M(-41.8%) | $397.66 M(-37.2%) |
| Sept 2020 | - | $633.06 M(+19.4%) |
| June 2020 | - | $530.18 M(+9.0%) |
| Mar 2020 | - | $486.19 M(-28.8%) |
| Dec 2019 | $683.29 M(+145.1%) | $683.29 M(+175.6%) |
| Sept 2019 | - | $247.94 M(-9.0%) |
| June 2019 | - | $272.52 M(-27.5%) |
| Mar 2019 | - | $375.81 M(+34.8%) |
| Dec 2018 | $278.82 M(+115.1%) | $278.82 M(-41.9%) |
| Sept 2018 | - | $479.89 M(-40.4%) |
| June 2018 | - | $805.49 M(+254.1%) |
| Mar 2018 | - | $227.50 M(+75.5%) |
| Dec 2017 | $129.63 M(+53.1%) | $129.63 M(-18.6%) |
| Sept 2017 | - | $159.18 M(+19.7%) |
| June 2017 | - | $132.99 M(+16.4%) |
| Mar 2017 | - | $114.22 M(+34.9%) |
| Dec 2016 | $84.69 M(-34.2%) | $84.69 M(+0.5%) |
| Sept 2016 | - | $84.28 M(-25.1%) |
| June 2016 | - | $112.53 M(+20.6%) |
| Mar 2016 | - | $93.34 M(-27.5%) |
| Dec 2015 | $128.80 M(-9.9%) | $128.80 M(+1.7%) |
| Sept 2015 | - | $126.59 M(+5.9%) |
| June 2015 | - | $119.49 M(-19.5%) |
| Mar 2015 | - | $148.35 M(+3.7%) |
| Dec 2014 | $143.00 M(-10.6%) | $143.00 M(+95.3%) |
| Sept 2014 | - | $73.22 M(-22.2%) |
| June 2014 | - | $94.08 M(-41.8%) |
| Mar 2014 | - | $161.78 M(+1.1%) |
| Dec 2013 | $159.97 M(+28.5%) | $159.97 M(-37.6%) |
| Sept 2013 | - | $256.41 M(-13.5%) |
| June 2013 | - | $296.54 M(+175.5%) |
| Mar 2013 | - | $107.65 M(-13.5%) |
| Dec 2012 | $124.48 M(+90.1%) | $124.48 M(+47.2%) |
| Sept 2012 | - | $84.56 M(-1.3%) |
| June 2012 | - | $85.64 M(+51.9%) |
| Mar 2012 | - | $56.39 M(-13.9%) |
| Dec 2011 | $65.48 M(-6.5%) | $65.48 M(+18.5%) |
| Sept 2011 | - | $55.26 M(-35.0%) |
| June 2011 | - | $85.02 M(-1.4%) |
| Mar 2011 | - | $86.20 M(+23.1%) |
| Dec 2010 | $70.05 M(-33.4%) | $70.05 M(-30.0%) |
| Sept 2010 | - | $100.12 M(+117.5%) |
| June 2010 | - | $46.04 M(-53.3%) |
| Mar 2010 | - | $98.59 M(-6.3%) |
| Dec 2009 | $105.25 M(-51.7%) | $105.25 M(-29.5%) |
| Sept 2009 | - | $149.29 M(-30.8%) |
| June 2009 | - | $215.79 M(-15.1%) |
| Mar 2009 | - | $254.06 M(+16.6%) |
| Dec 2008 | $217.92 M(+57.2%) | $217.92 M(-17.7%) |
| Sept 2008 | - | $264.68 M(-40.6%) |
| June 2008 | - | $445.72 M(+63.9%) |
| Mar 2008 | - | $271.94 M(+96.2%) |
| Dec 2007 | $138.61 M | $138.61 M(+35.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2007 | - | $102.40 M(-23.0%) |
| June 2007 | - | $132.96 M(-27.5%) |
| Mar 2007 | - | $183.42 M(+60.2%) |
| Dec 2006 | $114.51 M(+3037.4%) | $114.51 M(+9.9%) |
| Sept 2006 | - | $104.24 M(-1.1%) |
| June 2006 | - | $105.36 M(+6057.7%) |
| Mar 2006 | - | $1.71 M(-53.1%) |
| Dec 2005 | $3.65 M(-86.6%) | $3.65 M(-93.1%) |
| Sept 2005 | - | $53.22 M(+566.3%) |
| June 2005 | - | $7.99 M(-33.5%) |
| Mar 2005 | - | $12.01 M(-55.9%) |
| Dec 2004 | $27.25 M(-17.7%) | $27.25 M(+27.1%) |
| Sept 2004 | - | $21.45 M(-29.4%) |
| June 2004 | - | $30.37 M(-23.6%) |
| Mar 2004 | - | $39.76 M(+20.1%) |
| Dec 2003 | $33.12 M(-67.5%) | $33.12 M(-40.6%) |
| Sept 2003 | - | $55.79 M(-34.6%) |
| June 2003 | - | $85.32 M(+39.7%) |
| Mar 2003 | - | $61.09 M(-40.0%) |
| Dec 2002 | $101.86 M(-19.8%) | $101.86 M(+9.4%) |
| Sept 2002 | - | $93.08 M(-15.4%) |
| June 2002 | - | $110.02 M(+19.0%) |
| Mar 2002 | - | $92.45 M(-27.2%) |
| Dec 2001 | $127.01 M(+220.6%) | $127.01 M(+931.7%) |
| Sept 2001 | - | $12.31 M(-3.3%) |
| June 2001 | - | $12.74 M(+58.1%) |
| Mar 2001 | - | $8.06 M(-79.7%) |
| Dec 2000 | $39.62 M(+12.2%) | $39.62 M(-32.9%) |
| Sept 2000 | - | $59.03 M(-4.9%) |
| June 2000 | - | $62.04 M(-4.2%) |
| Mar 2000 | - | $64.73 M(+83.4%) |
| Dec 1999 | $35.30 M(+27.9%) | $35.30 M(-7.8%) |
| Sept 1999 | - | $38.30 M(+11.3%) |
| June 1999 | - | $34.40 M(+69.5%) |
| Mar 1999 | - | $20.30 M(-26.4%) |
| Dec 1998 | $27.60 M(-27.6%) | $27.60 M(-27.4%) |
| Sept 1998 | - | $38.00 M(-2.3%) |
| June 1998 | - | $38.90 M(+39.9%) |
| Mar 1998 | - | $27.80 M(-27.0%) |
| Dec 1997 | $38.10 M(+2.7%) | $38.10 M(+31.8%) |
| Sept 1997 | - | $28.90 M(-19.5%) |
| June 1997 | - | $35.90 M(+37.0%) |
| Mar 1997 | - | $26.20 M(-29.4%) |
| Dec 1996 | $37.10 M(-20.2%) | $37.10 M(+43.8%) |
| Sept 1996 | - | $25.80 M(+1.2%) |
| June 1996 | - | $25.50 M(+12.8%) |
| Mar 1996 | - | $22.60 M(-51.4%) |
| Dec 1995 | $46.50 M(+260.5%) | $46.50 M(+87.5%) |
| Sept 1995 | - | $24.80 M(+31.9%) |
| June 1995 | - | $18.80 M(+13.3%) |
| Mar 1995 | - | $16.60 M(+28.7%) |
| Dec 1994 | $12.90 M(-61.7%) | $12.90 M(-20.4%) |
| Sept 1994 | - | $16.20 M(-12.0%) |
| June 1994 | - | $18.40 M(-44.6%) |
| Mar 1994 | - | $33.20 M(-1.5%) |
| Dec 1993 | $33.70 M(+104.2%) | $33.70 M(+88.3%) |
| Sept 1993 | - | $17.90 M(-17.5%) |
| June 1993 | - | $21.70 M(-19.6%) |
| Mar 1993 | - | $27.00 M(+63.6%) |
| Dec 1992 | $16.50 M(-22.2%) | $16.50 M(+13.0%) |
| Sept 1992 | - | $14.60 M(+10.6%) |
| June 1992 | - | $13.20 M(-17.5%) |
| Mar 1992 | - | $16.00 M(-24.5%) |
| Dec 1991 | $21.20 M(+1077.8%) | $21.20 M(+17.1%) |
| Sept 1991 | - | $18.10 M(-46.1%) |
| June 1991 | - | $33.60 M(+115.4%) |
| Mar 1991 | - | $15.60 M(+766.7%) |
| Dec 1990 | $1.80 M | $1.80 M |
FAQ
- What is Ionis Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Ionis Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Ionis Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of IONS is $399.27 M
What is the all time high annual cash & cash equivalents for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high annual cash & cash equivalents is $869.19 M
What is Ionis Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, IONS annual cash & cash equivalents has changed by +$122.79 M (+44.41%)
What is Ionis Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of IONS is $334.61 M
What is the all time high quarterly cash and cash equivalents for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high quarterly cash and cash equivalents is $869.19 M
What is Ionis Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, IONS quarterly cash and cash equivalents has changed by -$17.45 M (-4.96%)